Remsima SC (infliximab)

pCPA File Number: 22667
Negotiation Status:
Concluded with an LOI
Indication(s):
Ulcerative Colitis
Sponsor/Manufacturer:
Celltrion Healthcare Canada Ltd.
CDA-AMC Project Number:
SR0816-001
pCPA Engagement Letter Issued:
Negotiation Process Concluded: